Literature DB >> 2422137

3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.

W J Moriconi, M Slavik, S Taylor.   

Abstract

3-Deazauridine (NSC 126849) is a structural analog of uridine that inhibits the biosynthesis of Cytidine-5'-Triphosphate by competitive inhibition of Cytidine Triphosphate synthetase which is considered to be the primary mode of action of this nucleoside analog. Despite a paucity of clinical attention given to this drug as a single agent, it has generated much enthusiasm as a biological response modulator because of its synergistic effect with a number of antitumor agents including Cytosine Arabinoside, 5-aza-2'-deoxycytidine, 5-azacytidine, thymidine and D-galactosamine, although only the cytosine arabinoside/3-Deazauridine combination has been explored clinically. In this paper, the current status of the drug and future perspectives will be discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2422137     DOI: 10.1007/bf00172020

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN: 0167-6997            Impact factor:   3.850


  78 in total

1.  Selective lethal effect of thymidine on human and mouse tumor cells.

Authors:  S S Lee; B C Giovanella; J S Stehlin
Journal:  J Cell Physiol       Date:  1977-09       Impact factor: 6.384

2.  Some properties of uridine-cytidine kinase from a human malignant lymphoma.

Authors:  N K Ahmed; A D Welch
Journal:  Cancer Res       Date:  1979-08       Impact factor: 12.701

3.  Inhibition of gross leukemia virus-induced plaque formation in XC cells by 3-deazauridine.

Authors:  W M Shannon; R W Brockman; L Westbrook; S Shaddix; F M Schabel
Journal:  J Natl Cancer Inst       Date:  1974-01       Impact factor: 13.506

4.  Transport of uridine and 6-azauridine in human lymphoblastoid cells. Specificity for the uncharged 6-azauridine molecule.

Authors:  J A Belt; A D Welch
Journal:  Mol Pharmacol       Date:  1983-01       Impact factor: 4.436

5.  Phase II study of 5-azacytidine in solid tumors.

Authors:  A J Weiss; G E Metter; T F Nealon; J P Keanan; G Ramirez; A Swaiminathan; W S Fletcher; S E Moss; R W Manthei
Journal:  Cancer Treat Rep       Date:  1977 Jan-Feb

6.  Studies on the mode of action of 3-deazapyrimidines. 1. Metabolism of 3-deazauridine and 3-deazacytidine in microbial and tumor cells.

Authors:  M C Wang; A Bloch
Journal:  Biochem Pharmacol       Date:  1972-04-15       Impact factor: 5.858

7.  Cellular differentiation, cytidine analogs and DNA methylation.

Authors:  P A Jones; S M Taylor
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

8.  Penetration of 3-deazauridine into human brain, intracerebral tumor, and cerebrospinal fluid.

Authors:  D J Stewart; J A Benvenuto; M Leavens; S W Hall; R S Benjamin; W Plunkett; K B McCredie; M A Burgess; T L Loo
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

9.  Rational design of arabinosyl nucleosides as antitumor and antiviral agents.

Authors:  W E Müller
Journal:  Jpn J Antibiot       Date:  1977-12

10.  Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.

Authors:  J Veselý; A Cihák
Journal:  Cancer Res       Date:  1977-10       Impact factor: 12.701

View more
  5 in total

1.  Molecular crowding facilitates bundling of IMPDH polymers and cytoophidium formation.

Authors:  Chia-Chun Chang; Min Peng; Jiale Zhong; Ziheng Zhang; Gerson Dierley Keppeke; Li-Ying Sung; Ji-Long Liu
Journal:  Cell Mol Life Sci       Date:  2022-07-14       Impact factor: 9.207

Review 2.  Phytotoxicity and Other Adverse Effects on the In Vitro Shoot Cultures Caused by Virus Elimination Treatments: Reasons and Solutions.

Authors:  Katalin Magyar-Tábori; Nóra Mendler-Drienyovszki; Alexandra Hanász; László Zsombik; Judit Dobránszki
Journal:  Plants (Basel)       Date:  2021-03-31

3.  Phase I clinical trial of continuous infusion cyclopentenyl cytosine.

Authors:  P M Politi; F Xie; W Dahut; H Ford; J A Kelley; A Bastian; A Setser; C J Allegra; A P Chen; J M Hamilton
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

Review 4.  CTP synthetase and its role in phospholipid synthesis in the yeast Saccharomyces cerevisiae.

Authors:  Yu-Fang Chang; George M Carman
Journal:  Prog Lipid Res       Date:  2008-04-07       Impact factor: 16.195

5.  Cytoophidium assembly reflects upregulation of IMPDH activity.

Authors:  Chia-Chun Chang; Wei-Cheng Lin; Li-Mei Pai; Hsuan-Shu Lee; Shinn-Chih Wu; Shih-Torng Ding; Ji-Long Liu; Li-Ying Sung
Journal:  J Cell Sci       Date:  2015-08-24       Impact factor: 5.285

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.